Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wheatgrass extract is a natural product derived from the young plantlets of the common wheat plant, *Triticum aestivum*. It is recognized for its rich profile of phytoconstituents, including chlorophyll, vitamins, minerals, and phenolic compounds, which contribute to its antioxidant, detoxifying, and anti-inflammatory properties. Research indicates that wheatgrass extract may exert neuroprotective effects by modulating the ERK/Akt-CREB-BDNF signaling pathway. Specifically, it has been shown to upregulate neuroprotective markers such as Brain-Derived Neurotrophic Factor (BDNF) and cAMP Response Element-Binding protein (CREB), while simultaneously downregulating inflammatory markers like TNF-α. Furthermore, wheatgrass extract has demonstrated the ability to regulate tau protein phosphorylation and prevent its aggregation in the hippocampal region, suggesting potential therapeutic utility in treating age-related memory impairment and neurodegenerative conditions like Alzheimer's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wheatgrass extract.